Dean Marilyn Speedie Tribute

A DECADE OF LEADERSHIP IN PHARMACEUTICAL RESEARCH, EDUCATION AND POLICY

March 28, 2008
1:00 - 5:00 p.m.
Cowles Auditorium
Hubert H. Humphrey Institute
West Bank, University of Minnesota

Wolfgang Sadée is Felts Mercer Professor of Medicine and Pharmacology, Chair, Department of Pharmacology, Professor of Pharmacy, Psychiatry and Medical Genetics, and Director of The Ohio State University's Program in Pharmacogenomics.  Dr. Sadée’s research interests include pharmacogenetics/pharmacogenomics of drug receptors and transporters, chemogenomics, anticancer drug discovery, and genetics of drug addiction, other CNS disorders, cardiovascular disease, and cancer.

Arthur Isak Applbaum is Professor of Ethics and Public Policy and Acting Director of the Edmond J. Safra Foundation Center for Ethics at Harvard University.  Dr. Applbaum's work on legitimate political authority, civil and official disobedience, and role morality has appeared in journals such as Philosophy and Public Affairs, Harvard Law Review, Ethics, and Legal Theory.  He is the author of Ethics for Adversaries, a book about the morality of roles in public and professional life.  He is a member of Harvard's Advisory Committee on Shareholder Responsibility and chairs the ethics advisory board of a stem cell research foundation.

Gene Orringer is Professor of Medicine, Executive Associate Dean for Faculty Affairs and Faculty Development, University of North Carolina, Chapel Hill, NC.  Dr. Orringer has served in his present position since 1999.  Prior to that he was Program Director of UNC's NIH-funded General Clinical Research Center (GCRC) for a ten year period.  His research activities are focused primarily on membrane transport properties of the normal human erythrocyte, and on its disordered physiology in a variety of pathological states, especially sickle cell disease. 

Lucinda Maine is Executive Vice President, American Association of Colleges of Pharmacy, Washington D.C . Dr. Maine has served in her current role at AACP since 2002.   Prior to 2002, she served as Senior Vice President for Policy, Planning and Communications for the American Pharmacists Association (APhA).  Dr. Maine’s primary efforts have involved analyzing trends in health care, assessing their implications for pharmacy practice, and advocating appropriate recognition for all pharmacists.